Study Showed that COVID-19 May Explain the Rise in Cancer but Didn’t Mention the Spike Protein

The American Cancer Society headlined

Over the last 30 years, the risk of dying from cancer has steadily declined, sparing some 4 million lives in the United States. This downward trend can partially be explained by big wins in smoking cessation, early cancer detection, and treatment advancements.

Cancer incidence, however, is on the rise for many common cancers. In the coming year, we’re expecting to hit a bleak milestone—the first time new cases of cancer in the US are expected to cross the 2-million mark. That’s almost 5,500 cancer diagnoses a day.

The ACS explains the higher trend with an aging population and cancer screening.

This trend is largely affected by the aging and growth of the population and by a rise in diagnoses of 6 of the 10 most common cancers—breast, prostate, endometrial, pancreatic, kidney, and melanoma. (The other 4 top 10 cancers are lung, colon and rectum, bladder, and non-Hodgkin lymphoma.)

In 2024, over 611,000 deaths from cancer are projected for the US. That’s more than 1,600 deaths from cancer each day.

However, the aging of the population is constant. In fact, during COVID-19, the deaths are mostly from older people. The ones most at risk for cancer. If ever, we should expect a lower incidence of cancer.

They also said that cancer screening can explain the rise. But the screening is the same. Chest x-ray, colonoscopy and CT-scans. No new technology can detect two million more cancers this year.

So what is different?

A study from the AIRC Institute of Molecular Oncology in Milan and the International Centre for Genetic Engineering and Biotechnology in Trieste, Italy could explain why.

Nature Cell Biology published that SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence in Nature Cell Biology on April 2023.

The authors showed that the SARS-CoV-2 that causes COVID-19 can cause DNA damage. Specifically the ORF6 (Open reading frame 6) and NSP 13 (Nonstructural Protein 13).

Mechanistically, SARS-CoV-2 proteins ORF6 and NSP13 cause degradation of the DNA damage response kinase CHK1 through proteasome and autophagy, respectively.

CHK1 loss leads to deoxynucleoside triphosphate (dNTP) shortage, causing impaired S-phase progression, DNA damage, pro-inflammatory pathways activation and cellular senescence.

Cancer results from DNA damage. The good news is that the body can correct DNA damage using its 53BP1 system.

The bad news is that the same paper also showed that the N or Nucleocapsid protein of SARS-CoV-2 impairs the function of 53BP1.

Furthermore, SARS-CoV-2 N-protein impairs 53BP1 focal recruitment by interfering with damage-induced long non-coding RNAs, thus reducing DNA repair.

They were able to confirm their results in mice and humans.

Key observations are recapitulated in SARS-CoV-2-infected mice and patients with COVID-19.

The ORF6, NSP13, and the N protein are absent in the COVID shots.

It is good research because it adds to our understanding of the relationship between COVID-19 and cancer.

But what about the spike protein of the SARS-CoV-2? Does it cause DNA damage and interfere with DNA repair, too?

That’s a valid question because the COVID-19 jabs contain the genetic sequence of the spike protein. The idea is to make the body produce the spike protein and generate an immune response to it.

So I downloaded the study, opened it as a PDF, searched for S protein and spike protein, and found the mentioned spike only in the reference.

Why is the spike protein not included? Do you think it is nice to know if the COVID shot that has been injected into billions of people all over the world does not cause cancer or if it can cause cancer?

A previous study may have an answer.

In October 2021, the journal Viruses peer-reviewed and published SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro.

From the abstract. Emphasis added.

Here, by using an in vitro cell line, we report that the SARS-CoV-2 spike protein significantly inhibits DNA damage repair, which is required for effective V(D)J recombination in adaptive immunity.

Mechanistically, we found that the spike protein localizes in the nucleus and inhibits DNA damage repair by impeding key DNA repair protein BRCA1 and 53BP1 recruitment to the damage site.

Our findings reveal a potential molecular mechanism by which the spike protein might impede adaptive immunity and underscore the potential side effects of full-length spike-based vaccines.

That study became sensational, and many quoted the results to highlight the potential dangers of the jabs being imposed/coerced/forced on people.

I wrote about it in Study: SARS-CoV-2 Spike Proteins Impaired DNA Repair That Can Lead to Defective Immunity and Cancers

However, the authors, with foreign-sounding names, retracted that study in May 2022. I can’t find the retraction statement now, but I read it before, and it had something to do with the methodology.

Were they threatened with loss of funding or deportation?

So why is it that no one else has made a study to clear the issue of whether the Spike protein injected into millions of people can cause cancer or not?

I will do that if I’m a health authority genuinely concerned about the people. I will do that if I’m the CEO of a company that sells these jabs. Does anyone care?

So why not? Are these people afraid of the truth, or is it all about money?

The COVID-19 jabs were started in 2021. Since then, there has been a rise in cancer cases. I wrote about them.

So, are the COVID-19 shots causing the rise in cancers? What do you think?

Truth heals. Lies kill. Don’t Get Sick!

Knowledge about Covid-19 is rapidly evolving. Stay current by subscribing. Feel free to share and like.

Follow me on Gettr, Truth Social, Gab, Parler, Twitter, Facebook, Follow, and Telegram.

If you find value in this website, please consider buying a coffee to show your support.

References:

Gioia U, Tavella S, et al. SARS-CoV-2 infection induces DNA damage through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence Nat Cell Biol. 2023 Apr;25(4):550-564. doi: 10.1038/s41556-023-01096-x. Epub 2023 Mar 9. PMID: 36894671; PMCID: PMC10104783.
Jiang H, Mei YF. SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses. 2021 Oct 13;13(10):2056. doi: 10.3390/v13102056. Retraction in: Viruses. 2022 May 10;14(5): PMID: 34696485; PMCID: PMC8538446.

As an Amazon Associate, I earn from qualifying purchases.